PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 1 filers reported holding PEAR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $178,500 | -84.9% | 700,000 | -30.0% | 1.14% | -67.7% |
| Q4 2022 | $1,180,000 | -42.2% | 1,000,000 | 0.0% | 3.54% | -2.4% |
| Q3 2022 | $2,040,000 | +32.5% | 1,000,000 | 0.0% | 3.62% | +129.5% |
| Q2 2022 | $1,540,000 | -69.5% | 1,000,000 | 0.0% | 1.58% | -23.4% |
| Q1 2022 | $5,050,000 | -18.5% | 1,000,000 | 0.0% | 2.06% | -26.7% |
| Q4 2021 | $6,200,000 | – | 1,000,000 | – | 2.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Arboretum Ventures, Inc. | 10,859,050 | $54,838,000 | 44.55% |
| 5AM Venture Management, LLC | 18,631,771 | $94,090,000 | 20.55% |
| TB Alternative Assets Ltd. | 2,071,865 | $10,463,000 | 3.59% |
| Palantir Technologies Inc. | 1,000,000 | $5,050,000 | 2.06% |
| SB Global Advisers Ltd | 12,100,078 | $61,105,000 | 1.92% |
| EDBI Pte Ltd | 427,070 | $2,157,000 | 1.44% |
| Temasek Holdings (Private) Ltd | 26,803,573 | $135,358,044 | 0.57% |
| Blue Water Life Science Advisors, LP | 194,686 | $983,000 | 0.47% |
| Sarissa Capital Management LP | 500,356 | $2,527,000 | 0.24% |
| Perceptive Advisors | 926,232 | $4,677,000 | 0.09% |